Business context and reporting period
Caesarstone Ltd. (Nasdaq: CSTE) filed its annual Form 20-F for the fiscal year ended December 31, 2020. The company manufactures and resells engineered quartz and porcelain surfaces, primarily for residential countertops, and sells in more than 50 countries. Results are presented in U.S. dollars under U.S. GAAP; the filing is an annual report, not a standalone fourth-quarter filing.
Financial performance and liquidity
| Metric | 2020 | 2019 |
|---|---|---|
| Revenue | $486.4 million | $546.0 million |
| Gross profit / margin | $133.9 million / 27.5% | $148.6 million / 27.2% |
| Operating income / margin | $22.5 million / 4.6% | $24.7 million / 4.5% |
| Net income attributable to controlling interest | $7.2 million; $0.21 per share | $12.9 million; $0.37 per share |
| Adjusted EBITDA / margin | $62.1 million / 12.8% | $69.0 million / 12.6% |
| Adjusted net income attributable to controlling interest | $16.5 million / 3.4% margin | $26.7 million / 4.9% margin |
| Net cash from operating activities | $47.6 million | $83.0 million |
| Capital expenditures | $19.8 million | $23.6 million |
Finance expense, net rose to $10.2 million from $5.6 million, principally reflecting unfavorable foreign exchange effects and derivative losses. The NIS appreciated 7.5% against the U.S. dollar during 2020; management attributed approximately $6.8 million of finance expense to this movement.
At year-end, cash, cash equivalents and short-term bank deposits were $114.2 million, with available-for-sale marketable securities of $19.0 million. Working capital was $228.7 million. Bank debt was $22.7 million, including current maturities; total liabilities were $325.9 million. Operating cash flow declined year over year, while investing activities used $68.3 million, including $19.8 million of capital expenditure, $19.2 million net investment in marketable securities and $29.0 million of acquisition consideration. Financing activities used $6.1 million, including $4.8 million of dividends. Cash and cash equivalents decreased by $25.1 million during the year.
Material changes versus comparable periods
- Revenue fell 10.9% year over year; management attributed the decrease mainly to COVID-19-related disruption and an approximately 11% decline in sales volume. U.S. revenue fell 17.2%; Canada fell 15.7% and Australia 4.2%.
- Gross margin improved by 30 basis points, which management attributed to efficiency gains, lower raw-material costs and improved product mix, partly offset by lower sales volume and prices and a less favorable regional mix.
- Operating expenses declined to $111.4 million from $124.0 million, including lower marketing and selling costs and legal contingencies. Net income nevertheless declined, as higher finance expense and a higher effective tax rate offset operating improvements.
- Operating cash flow fell by $35.4 million, chiefly reflecting less favorable working-capital movements than in 2019.
- In October 2020, Caesarstone acquired 55% of porcelain producer Lioli in India. In December, it acquired U.S. stone supplier Omicron for approximately $19 million, including assumed debt. Integration was ongoing at year-end.
Outlook, commentary, risks and unusual items
The filing provides no specific financial guidance. Management said 2021 capital expenditures were expected to increase from recent-year levels as postponed operational investments resumed, and that it intended to increase OEM purchases. It identified the U.S. as a key growth opportunity and planned continued investment in direct distribution and expanded product offerings. The company said the duration and effects of the pandemic remained uncertain.
Key risks include demand weakness in renovation and residential construction; intense competition and pricing pressure; foreign-exchange exposure; raw-material and supplier concentration; and dependence on key retailers and geographic markets. Four markets—the U.S., Australia (including New Zealand), Canada and Israel—represented 87.3% of 2020 revenue. COVID-19 disrupted operations and demand, while recruitment challenges at the Sdot-Yam plant could constrain production.
Silicosis litigation is a major contingency. At December 31, 2020, the company recorded approximately $42.3 million for bodily-injury claims and related unasserted Israeli claims, and reported $8.0 million of insurance receivables. Outcomes remain uncertain, and insurance coverage for newly diagnosed claims is limited or excluded in some jurisdictions. A proposed Israeli class-action settlement of approximately $2.8 million remained subject to court approval. Separately, the company paid WOMAG approximately $8.9 million in January 2021; further disputed amounts and loss-of-profits claims were scheduled for a hearing.
The company reported an unqualified audit opinion and effective internal control over financial reporting. The auditors’ critical audit matters included the silica-claims provision, acquisition accounting and goodwill valuation. Management also disclosed that goodwill was $47.5 million and that market capitalization below book equity was an impairment indicator; no impairment was recorded.
Important facts for investors to verify
- Whether demand, pricing and sales volumes recover after the pandemic-related decline, particularly in North America and Australia.
- Whether Lioli and Omicron integration, acquisition assumptions and goodwill valuations prove supportable, and whether Lioli’s property title or regulatory matters create additional exposure.
- Developments in silicosis claims, insurance recoveries, the proposed class settlement and the remaining WOMAG proceedings.
- Liquidity and cash conversion, including working-capital needs, planned higher capital spending, acquisition-related debt and the company’s ability to meet lease and other obligations.
- Foreign-exchange effects, especially NIS appreciation and Australian- and Canadian-dollar movements, and the extent to which derivatives mitigate exposures.
- Renewal and terms of the IKEA arrangements, and whether customer concentration, raw-material supply concentration and related-party agreements affect future results.